Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M88,678Revenue (TTM) $M37,472Net Margin (%)1.1Altman Z-Score1.1
Enterprise Value $M110,898EPS (TTM) $0.1Operating Margin %6.6Piotroski F-Score4
P/E(ttm)236Beneish M-Score-2.7Pre-tax Margin (%)4.1Higher ROA y-yN
Price/Book50710-y EBITDA Growth Rate %1.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %7.6Current Ratio1.0Lower Leverage y-yY
Price/Free Cash Flow25.4y-y EBITDA Growth Rate %-76.5ROA % (ttm)0.5Higher Current Ratio y-yN
Dividend Yield %5.8PEG32.0ROE % (ttm)10.7Less Shares Outstanding y-yN
Payout Ratio %1,429Shares Outstanding M4,872ROIC % (ttm)5.0Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

GLAXF is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22-17.36view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14-14view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29243.67view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1251.5view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1429.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1251.5view

Quarterly/Annual Reports about GLAXF:

    News about GLAXF:

    Articles On GuruFocus.com
    Asset Sales, New Projects Fuel 6.7% Yield Dec 07 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 
    Jeff Auxier Curbs Multiple Positions in 3rd Quarter Dec 01 2016 
    Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders Nov 28 2016 
    6 Worthy Dividend Stocks Down 10% or More Nov 22 2016 
    Kahn Brothers Adds to 4 Holdings in 3rd Quarter Nov 02 2016 
    Tweedy Browne Adds to 5 Holdings, Trims 2 Others in 3rd Quarter Oct 11 2016 
    Examine Cognizant's Recent Developments Closely Oct 06 2016 
    Novartis Is Surviving Oct 03 2016 
    Strong Revenue Points to Gains at GlaxoSmithKline Oct 01 2016 

    More From Other Websites
    [$$] Big pharma should beware bite of small watchdogs Dec 07 2016
    Pfizer Takes $106 Million Fine From U.K. for Price Hike of Epilepsy Drug Dec 07 2016
    Britain fines Pfizer record $107 mln for huge drug price hike Dec 07 2016
    Drug firms fined over 2,600% NHS price hike for epilepsy treatment Dec 07 2016
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016
    GSK insider Waterhouse to head drugmaker's HIV unit ViiV Dec 05 2016
    GSK insider Waterhouse to head drugmaker's HIV unit ViiV Dec 05 2016
    Better buy: GlaxoSmithKline plc vs Shire plc Dec 05 2016
    What Smart Money Thinks About GlaxoSmithKline plc (ADR) (GSK) Dec 04 2016
    How to Buy GlaxoSmithKline at a 15% Discount Dec 02 2016
    GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala Dec 02 2016
    Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD Dec 02 2016
    GSK biotech asthma drug wins UK approval after extra price cut Nov 30 2016
    GSK biotech asthma drug wins UK approval after extra price cut Nov 30 2016
    GlaxoSmithKline PLC (ADR) (GSK) Targeting Blockbuster Sales With Shingles Vaccine On EU Approval Nov 30 2016
    GlaxoSmithKline Plans Nigeria Health Boost After Drinks Sale Nov 29 2016
    Should You Buy 3M Co (MMM)? Nov 29 2016
    Injections, implants tested as new weapons to prevent HIV Nov 29 2016
    Injections, implants tested as new weapons to prevent HIV Nov 29 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)